New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques

Rajesh Chandra, Shunichi Oya, Mei Ping Kung, Catherine Hou, Lee-Way Jin, Hank F. Kung

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

A series of 18F fluoropegylated diphenylacetylenes as probes for binding to Aβ plaques were successfully prepared. These relatively rigid acetylenes, 12a, 12b, 14a, and 14b, displayed high binding affinities in postmortem AD brain homogenates (Ki ranging from 1.2 to 2.9 nM). In vivo biodistribution in normal mice exhibited excellent initial brain penetrations (4.42, 4.55, 5.41, and 6.78% dose/g at 2 min for [ 18F]12a, 12b, 14a, and 14b, respectively). [18F]12b and [18F]14b, with a longer fluoropegylated unit, that is, n = 3, showed faster brain washout at 30 min postinjection (0.42 and 1.57% dose/g) as compared to the shorter fluoropegylated chain ligands, that is, [18F]12a and [18F]14a (1.03 and 3.69% dose/g). Autoradiography and homogenate binding confirmed the high binding signal due to Aβ plaques. These preliminary results suggest that the novel diphenylacetylenes may be potentially useful for imaging of Aβ plaques in the brain of patients with Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)2415-2423
Number of pages9
JournalJournal of Medicinal Chemistry
Volume50
Issue number10
DOIs
StatePublished - May 17 2007

Fingerprint

Amyloid Plaques
Positrons
Amyloid
Brain
Electrons
Imaging techniques
Alkynes
Autoradiography
Alzheimer Disease
Ligands
biphenylacetylene

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques. / Chandra, Rajesh; Oya, Shunichi; Kung, Mei Ping; Hou, Catherine; Jin, Lee-Way; Kung, Hank F.

In: Journal of Medicinal Chemistry, Vol. 50, No. 10, 17.05.2007, p. 2415-2423.

Research output: Contribution to journalArticle

Chandra, Rajesh ; Oya, Shunichi ; Kung, Mei Ping ; Hou, Catherine ; Jin, Lee-Way ; Kung, Hank F. / New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques. In: Journal of Medicinal Chemistry. 2007 ; Vol. 50, No. 10. pp. 2415-2423.
@article{c0402cc4bb874806b65180f6db282e0b,
title = "New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques",
abstract = "A series of 18F fluoropegylated diphenylacetylenes as probes for binding to Aβ plaques were successfully prepared. These relatively rigid acetylenes, 12a, 12b, 14a, and 14b, displayed high binding affinities in postmortem AD brain homogenates (Ki ranging from 1.2 to 2.9 nM). In vivo biodistribution in normal mice exhibited excellent initial brain penetrations (4.42, 4.55, 5.41, and 6.78{\%} dose/g at 2 min for [ 18F]12a, 12b, 14a, and 14b, respectively). [18F]12b and [18F]14b, with a longer fluoropegylated unit, that is, n = 3, showed faster brain washout at 30 min postinjection (0.42 and 1.57{\%} dose/g) as compared to the shorter fluoropegylated chain ligands, that is, [18F]12a and [18F]14a (1.03 and 3.69{\%} dose/g). Autoradiography and homogenate binding confirmed the high binding signal due to Aβ plaques. These preliminary results suggest that the novel diphenylacetylenes may be potentially useful for imaging of Aβ plaques in the brain of patients with Alzheimer's disease.",
author = "Rajesh Chandra and Shunichi Oya and Kung, {Mei Ping} and Catherine Hou and Lee-Way Jin and Kung, {Hank F.}",
year = "2007",
month = "5",
day = "17",
doi = "10.1021/jm070090j",
language = "English (US)",
volume = "50",
pages = "2415--2423",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - New diphenylacetylenes as probes for positron emission tomographic imaging of amyloid plaques

AU - Chandra, Rajesh

AU - Oya, Shunichi

AU - Kung, Mei Ping

AU - Hou, Catherine

AU - Jin, Lee-Way

AU - Kung, Hank F.

PY - 2007/5/17

Y1 - 2007/5/17

N2 - A series of 18F fluoropegylated diphenylacetylenes as probes for binding to Aβ plaques were successfully prepared. These relatively rigid acetylenes, 12a, 12b, 14a, and 14b, displayed high binding affinities in postmortem AD brain homogenates (Ki ranging from 1.2 to 2.9 nM). In vivo biodistribution in normal mice exhibited excellent initial brain penetrations (4.42, 4.55, 5.41, and 6.78% dose/g at 2 min for [ 18F]12a, 12b, 14a, and 14b, respectively). [18F]12b and [18F]14b, with a longer fluoropegylated unit, that is, n = 3, showed faster brain washout at 30 min postinjection (0.42 and 1.57% dose/g) as compared to the shorter fluoropegylated chain ligands, that is, [18F]12a and [18F]14a (1.03 and 3.69% dose/g). Autoradiography and homogenate binding confirmed the high binding signal due to Aβ plaques. These preliminary results suggest that the novel diphenylacetylenes may be potentially useful for imaging of Aβ plaques in the brain of patients with Alzheimer's disease.

AB - A series of 18F fluoropegylated diphenylacetylenes as probes for binding to Aβ plaques were successfully prepared. These relatively rigid acetylenes, 12a, 12b, 14a, and 14b, displayed high binding affinities in postmortem AD brain homogenates (Ki ranging from 1.2 to 2.9 nM). In vivo biodistribution in normal mice exhibited excellent initial brain penetrations (4.42, 4.55, 5.41, and 6.78% dose/g at 2 min for [ 18F]12a, 12b, 14a, and 14b, respectively). [18F]12b and [18F]14b, with a longer fluoropegylated unit, that is, n = 3, showed faster brain washout at 30 min postinjection (0.42 and 1.57% dose/g) as compared to the shorter fluoropegylated chain ligands, that is, [18F]12a and [18F]14a (1.03 and 3.69% dose/g). Autoradiography and homogenate binding confirmed the high binding signal due to Aβ plaques. These preliminary results suggest that the novel diphenylacetylenes may be potentially useful for imaging of Aβ plaques in the brain of patients with Alzheimer's disease.

UR - http://www.scopus.com/inward/record.url?scp=34249029282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249029282&partnerID=8YFLogxK

U2 - 10.1021/jm070090j

DO - 10.1021/jm070090j

M3 - Article

VL - 50

SP - 2415

EP - 2423

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 10

ER -